Breast health care a review

Journal of Nurse-Midwifery

Volumn 43, Issue 6, 1998, Pages 406-430

  McCool, William F ^a,b   Stone Condry, Margot ^a,c   Bradford, Heather M ^a,d,e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Medical University of South Carolina   (United States)

^c YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^d Hill Health Center   (United States)

^e BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST DISEASE; FEMALE; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; HUMAN; NURSING; NURSING ASSESSMENT; PHYSICAL EXAMINATION; PHYSIOLOGY; REVIEW;

BREAST; BREAST DISEASES; FEMALE; HUMANS; NURSING ASSESSMENT; PHYSICAL EXAMINATION;

EID: 0032197371     PISSN: 00912182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-2182(98)00065-2     Document Type: Article

References (179)

1. Varney H. Varney's Midwifery. 3rd ed. Sudbury (MA): Jones and Bartlett Publishers, 1997.
2. Nettles-Carlson B. Problems of the breast. In: Fogel CI, Woods NF, editors. Women's Health Care. Thousand Oaks (CA): Sage Publications, 1995.
3. Speroff L, Glass R, Case N. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore (MD): Williams & Wilkins, 1994.
4. Zilbach, J. Female adolescence: toward a separate line of female development. In: Sugar M, editor. Female adolescent development. 2nd ed. New York: Brunner/Mazel, 1993.
5. Winckel F. A handbook of diseases of women. Philadelphia: P. Blakiston, 1889.
6. Danforth DN, editor. Obstetrics and gynecology. 3rd ed. New York: Harper and Row, 1977.
7. Berger K, Bostwick J. A woman's decision: breast care, treatment, and reconstruction. St. Louis: Quality Medical Publishing, Inc., 1994.
8. Dupont WD, Page DL, Pari FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-15.
9. Gulay H, Bora S, Kilicturgay S, Hamaloglu E, Goksei HA. Management of nipple discharge. J Am Coll Surg 1994;178:471-4.
10. Berek JS, editor. Novaks' gynecology. 12th ed. Baltimore: Williams & Wilkins, 1996.
11. Popkin DR, Peddle LJ, editors. Women's health today. New York: Parthenon Publishing Group, 1994.
12. Love S, Lindsey K. Dr. Susan Loves's breast book. 2nd ed. Addison-Wesley Publishing Company, 1995.
13. Kelsey JL, Berstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996;17:47-67.
14. McPherson K, Steel CM, Dixon JM. Breast cancer: epidemiology, risk factors, and genetics. BMJ 1994;309:1003-6.
15. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993;15:7-16.
16. Kelsey JL. Breast cancer epidemiology: summary and future directions. Epidemiol Rev 1993;15:256-63.
17. Mettlin C. The relationship of breast cancer epidemiology to screening recommendations. Cancer 1994;74Suppl 1:228-30.
18. Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 1994;6:541-8.
19. Thompson WD. Genetic epidemiology of breast cancer. Cancer 1994;74Suppl 1:279-87.
20. Scott JR, DiSaia PJ, Hammond CB, Spellacy WN, editors. Danforth's obstetrics and gynecology. 7th ed. Philadelphia: J.B. Lippincott Company, 1994.
21. American Cancer Society. Breast cancer information [Online]. Available at: http://www.cancer.org/bottomcancinfo.html. Accessed September 15, 1998.
22. Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996;6:399-412.
23. Stratton MR. Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 1996;5:1515-9.
24. Daudt A, Alberg AJ, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 1996;8:455-61.
25. Paskett ED, McMahon K, Tatum C, et al. Clinic-based interventions to promote breast and cervical cancer screening. Prev Med 1998;27:120-8.
26. Wolff, M. S., Weston, A. Breast cancer risk and environmental exposures. Environ Health Perspect 1997; 105 Suppl 4:891-6.
27. Lierman LM. Discovery of breast changes. Cancer Nurs 1988;11:352-61.
28. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 1997;277:997-1003.
29. Woods NF. Women's bodies. In: Fogel CI, Woods NF, editors. Women's Health Care. Thousand Oaks, (CA): Sage Publications, 1995.
30. Bodian C. Biologic markers in breast tissue: benign breast disease, carcinoma in situ, and breast cancer risk. Epidemiol Rev 1993;15:177-87.
31. The Boston Women's Health Book Collective. The new our bodies, ourselves. Magnolia (MA): Peter Smith, 1996.
32. Drukker B. The breast. In: Seltzer VL, Pearse, WH. Women's primary health care. New York: McGraw-Hill, Inc, 1995.
33. Brucker M, Scharbo-DeHaan M. Breast disease: the role of the nurse-midwife. J Nurse Midwifery 1991;36:63-73.
34. Netter, F. The CIBA collection of medical illustrations, Vol. 2: reproductive system. Summit (NJ): CIBA, 1997.
35. Tanner JM. Fetus into man: physical growth from conception to maturity. Cambridge: Harvard University Press, 1978.
36. Morris N, Udry J. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980;9:271-80.
37. Edge V, Miller M. Women's health care. Mosby, 1994.
38. Semmens J. Mid-life sexuality: enrichment and problem solving. Dallas (TX): Essential Medical Information Systems, 1990.
39. Bates B. A guide to physical examination and history taking, 6th ed. Philadelphia: Lippincott-Raven Publishers, 1994.
40. Grady K. The efficacy of breast self-examination. J Gerontology, 1992;47:69-74.
41. McCool W. Barriers to breast cancer screening in older women: a review. J Nurse Midwifery 1994;39:283-99.
42. Hughes JE, Royle GT, Buchanan R, Taylor I. Depression and social stress among patients with benign breast disease. Br J Surg 1986;73:997-9.
43. Fletcher S, O'Malley M. Clinical breast examination. Hosp Pract 1986;21:80-9.
44. Cady B, Steele G, Morrow M, et al. Evaluation of common breast problems: guidance for primary care providers. CA Cancer J Clin 1998;48:49-63.
45. Henderson MM. Nutritional aspects of breast cancer. Cancer 1995;76Suppl 10:2053-8.
46. Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol 1992;2:597-609.
47. Greenwald P, Sherwood K, McDonald SS. Fat, caloric intake, and obesity: lifestyle risk factors for breast cancer. J Am Diet Assoc 1997;97Suppl 7:S24-S30.
48. Brinton LA. Ways that women may possibly reduce risk of breast cancer. J Natl Cancer Inst 1994;86:1371-2.
49. Lamarine R. Selected health and behavioral effects related to the use of caffeine. J Community Health 1994;19:449-66.
50. Minton JP, Foecking MK, Webster DJ, Matthews RH. Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease. Am J Ob Gynecol 1979;135:157-8.
51. Hunter D, Willett W. Nutrition and breast cancer. Cancer Causes Control 1996;7:56-68.
52. Bowlin SJ, Leske MC, Varma A, Nasca P, Weinstein A, Caplan L. Breast cancer risk and alcohol consumption: results from a large case-control study. Int J Epidemiol 1997;26:915-23.
53. Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269-75.
54. Friedenreich C, Rohan T. A review of physical activity and breast cancer. Epidemiology 1995;6:311-7.
55. Stoll B. Diet and exercise regimens to improve breast carcinoma prognosis. Cancer 1996;78:2465-70.
56. Buyske J, Mackarem G, Ulmer B, Hughes K. Breast cancer in the nineties. AORN J 1996;64:64-72.
57. Maurer F. A peer education model for teaching breast self-examination to undergraduate college women. Cancer Nurs 1997;20:49-61.
58. Auvinen A, Elovainio L, Hakama M. Breast self-examination and survival from breast cancer: a prospective study. Breast Cancer Res Treat 1996;38:161-8.
59. Holmberg L, Anders E, Calle E, Mokdad A, Byers T. Breast cancer mortality in relation to self-reported use of breast self-examination: a cohort study of 450,000 women. Breast Cancer Res Treat 1997;43:137-40.
60. Leslie N, Roche B. Evaluation of a breast examination facilitation device. J Adv Nurs 1995;21:28-33.
61. Jacob T, Penn N, Giebink J, Bastien R. A comparison of breast self-examination and clinical examination. J Natl Med Assoc 1994;86:40-5.
62. Hill D, White V, Jolley D, Mapperson K. Self-examination of the breast: is it beneficial? Meta-analysis of studies investigating breast self-examination and extent of disease in patients with breast cancer. BMJ 1988;279:271-5.
63. Wood R. Breast self-examination proficiency in older women: measuring the efficacy of video self-instruction kits. Cancer Nurs 1996;19:429-36.
64. Miller A, Baines C, Turnball C. The role of the nurse examiner in the National Breast Screening study. Can J Public Health 1991;82:162-7.
65. Silverstein M. Recent advances: diagnosis and treatment of early breast cancer. BMJ 1997;314:1736-9.
66. Mittra I. Breast screening: the case for physical examination without mammography. Lancet 1994;343:342-4.
67. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten-to-fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
68. Reintgen D, Berman C, Cox C. The anatomy of missed breast cancers. Surg Oncol 1993;2:65-75.
69. Dodd G. American Cancer Society guidelines from past to present. Cancer 1993;72:1429-32.
70. American College of Obstetricians and Gynecologists. April 1997 press statement on mammography screening guidelines [Online]. Available at: http://www.acog.com/from_home/publications/press_releases/nr-mammos.htm. Accessed September 15, 1998.
71. Austoker J. Cancer prevention in primary care: screening and self-examination for breast cancer. BMJ 1994;309:168-74.
72. Huey, F. NIH consensus statement on breast cancer screening for women in their 40s: how will it affect patient care? Medscape Women's Health. Available at: http://www.medscape.com. Accessed May 23, 1998.
73. Philips M, Balducci L. Current management of breast cancer. Am Fam Physician 1996;53:657-65.
74. Haagensen CD. Diseases of the breast, 3rd ed. Philadelphia: W.B. Saunders Company, 1986.
75. Love S, Gelman R, Silen W. Fibrocystic "disease" of the breast - a nondisease? N Engl J Med 1982;307:1010-4.
76. Ketcham A, Moffat F. Vexed surgeons, perplexed patients, and breast cancers which may not be cancer. Cancer 1990;65:387-93.
77. Isaacs J. Benign tumors of the breast. Obstet Gynecol Clin North Am 1994;21:487-97.
78. Bundred NJ, West RR, Dowd JO, Mansel RE, Hughes LE. Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br J Cancer 1991;64:953-5.
79. Haagensen CD. The relationship of gross cystic disease of the breast and carcinoma. Ann Surg 1977;185:375-6.
80. DuPont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
81. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997;6:297-301.
82. Unic I, Stalmeier PF, Peer PG, van Daal WA. A review on family history of breast cancer: screening and counseling proposals for women with familial (non-hereditary) breast cancer. Patient Educ Counseling 1997;32:117-27.
83. Jones R, Hendler F. Fibrocystic changes of the breast. In: Hindle W, editor. Breast disease for gynecologists. East Norwalk (CT): Appleton and Lange, 1990.
84. Dupont WD, Page DL, Pari FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-5.
85. Carty N, Carter C, Rubin C, Ravichandran D, Royle G, Taylor I. Management of fibroadenoma of the breast. Ann R Coll Surg Engl 1995;77:127-30.
86. Dixon J, Dobie V, Lamb J, Walsh J, Chetty U. Assessment of the acceptability of conservative management of fibroadenoma of the breast. Br J Surg 1996;83:264-5.
87. Jonides L, Rudy C, Walsh S. Breast masses in adolescent girls. J Pediatr Health Care 1992;274:287-8.
88. Williams S, Kaplan P, Petersen J, Lieberman R. Mammography in women under age 30: is there clinical benefit? Radiology 1986;161:49-51.
89. Branch LG. Breast health. In: Youngkin EQ, Davis MS, editors. Women's health: a primary care clinical guide. Norwalk (CT): Appleton and Lange; 1994.
90. Love S, Schnitt S, Connolly J, Shirley R. Benign breast diseases. In: Harris J, Hellman S, Henderson I, Kinne D, editors. Breast diseases. Philadelphia: Lippincott, 1987.
91. Petrakis N. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 1993;2:3-10.
92. Jardines L. Management of nipple discharge. Am Surg 1996; 62:119-22.
93. Fiorica J. Nipple discharge. Obstet Gynecol Clin North Am 1994;21:453-60.
94. Goroll AH, May LA, Mulley AG. Primary care medicine: office evaluation and management of the adult patient. Philadelphia: J.B. Lippincott Company, 1995.
95. Miller, J. Benign breast disorders. In: Lemcke D, Pattison J, Marshall L, Cowley D, editors. Primary care of women. Norwalk (CT): Appleton and Lange, 1995.
96. Gregerman R. Selected endocrine problems: disorders of the pituitary, adrenal, and parathyroid glands; pharmacological use of steroids; hypo- and hypercalcemia; osteoporosis; water metabolism; hypoglycemia. In: Barker L, Burton, J, Zieve P, editors. Principles of ambulatory medicine, 4th ed. Baltimore: Williams & Wilkins, 1994.
97. Pearson C. NWHN joins health research group in suit against dangerous lactation suppression drug: Parlodel withdrawn from market. The Network News: National Women's Health Network 1994;19:4.
98. Jacobs AJ, Gast MJ. Practical gynecology: clinical manual. Norwalk (CT): Appleton and Lange, 1994.
99. Clark R. Infections during the postpartum period. J Obstet Gynecol Neonatal Nurs 1995;24:542-8.
100. Kuske R. Breast abnormalities. In: Jacobs A, Gast M, editors. Practical gynecology. Norwalk (CT): Appleton and Lange, 1994.
101. Lawrence R. Breastfeeding: A guide for the medical profession, 4th ed. St. Louis: Mosby, 1994.
102. Riordan J, Auerbach K. Breastfeeding and human lactation. Sudbury (MA): Jones and Bartlett, 1993.
103. Leis H. Management of nipple discharge. World J Surg 1989;13:736-42.
104. Sitruk-Ware R, Sterkers N, Mauvais-Jarvis P. Benign breast disease I: hormonal investigation. Obstet Gynecol 1979;53:457-60.
105. Watt-Boolsen S, Eskildsen PC, Blaehr H. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast. Cancer 1985;56:500-2.
106. Kumar S, Mansel RE, Hughes LE, et al. Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease. Cancer 1984;53:1311-5.
107. Ayers JW, Gidwani GP. The "luteal breast": hormonal and sonographic investigation of benign breast disease in patients with cyclic mastalgia. Fertil Steril 1983;40:779-84.
108. Preece PE, Mansel RE, Bolton PM, Hughes LM, Baum M, Gravelle IH. Clinical syndromes of mastalgia. Lancet 1976;2:670-3.
109. Raslan F. Benign breast pain. Professional Care Mother Child 1996;3:61-2.
110. Blichert-Toft M, Anderson AN, Henriksen OB, Mygind T. Treatment of mastalgia with bromocriptine: a double-blind cross-over study. BMJ 1979;1:237.
111. Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HF. Clinical studies with an antigonadotropin-danazol. Fertil Steril 1971;22:102-12.
112. Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1986;1:287-8.
113. Dondero T, Lichtman R. The breasts. In: Lichtman R, Papera S, editors. Gynecology: well-women care. Norwalk (CT): Appleton and Lange, 1990.
114. Deapen DM, Pike MC, Casagrande JT, Brody GS. The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study. Plast Reconstr Surg 1986;77:361-8.
115. Zones J. New developments in silicone breast implants regulations. Network News: National Women's Health Network 1991;16:1-4.
116. Brown S, Silverman B, Berg W. Rupture of silicone-gel breast implants: causes, sequelae, diagnosis. Lancet 1997;350:1531-7.
117. Gabriel S, Woods J, O'Fallon W, Beard C, Kurland L, Melton LJ III Complications leading to surgery after breast implantation. N Engl J Med 1997;336:677-82.
118. Kroll S. Immediate reconstruction: a review. Ann Chir Gynaecol 1997;86:5-12.
119. Wickman M, Jurell G. Low capsular contraction rate after primary and secondary breast reconstruction with a textured expander prosthesis. Plast Reconstr Surg 1997;99:692-7.
120. Wallace M, Wallace A, Lee J, Dobke M. Pain after breast surgery: a survey of 282 women. Pain 1996;66:195-205.
121. Robinson OG, Bradley EL, Wilson DS. Analysis of explanted silicone implants: a report of 300 patients. Ann Plast Surg 1995;34:1-6.
122. Osteen R. Reconstruction after mastectomy. Cancer 1995;76Suppl 10:2070-4.
123. Gabriel S, O'Fallon W, Kurland L, Beard C, Woods J, Melton LJ III. Risk of connective-tissue diseases and other disorder after breast implantation. N Engl J Med 1994;330:1697-702.
124. Jenkins M, Friedman HI, von Recum AF. Breast implants: facts, controversy, and speculations for future research. J Invest Surg 1996;9:1-12.
125. Dowden R. Mammography after implant breast reconstruction. Plast Reconstr Surg 1995;96:119-21.
126. Widdice L. The effects of breast reduction and breast augmentation surgery on lactation: an annotated bibliography. J Hum Lactation 1993;9:161-7.
127. Raispis T, Zehring R, Downey D. Long-term functional results after reduction mammaplasty. Ann Plast Surg 1995;34:113-5.
128. Klassen A, Fitzpatrick R, Jenkinson C, Goodacre T. Should breast reduction surgery be rationed? A comparison of the health status of patients before and after treatment: postal questionnaire survey. BMJ 1996;313:454-7.
129. Zukowski M, Ash K, Klink B, Reid D, Messa A. Breast reduction under intravenous sedation: a review of 50 cases. Plast Reconstr Surg 1996;97:952-6.
130. Short K, Ringler S, Bengston B, Hunstad J, Henry E. Reduction mammaplasty: a safe and effective outpatient procedure. Aesthetic Plast Surg 1996;20:513-8.
131. Davies B, Lewis R, Pennington G. Reduction mammaplasty: a comparison of outpatient and inpatient procedures. Aesthetic Plast Surg 1996;20:77-80.
132. Beer G, Kompatscher P, Hergen K. Diagnosis of breast tumors after breast reduction. Aesthetic Plast Surg 1996;20:391-7.
133. Marshall D, Callan P, Nicholson W. Breastfeeding after reduction mammaplasty. Br J Plast Surg 1994;47:167-9.
134. Berg JW, Hutter RV. Breast cancer. Cancer 1995;75Suppl 1:257-69.
135. McNelis J, Wise L. Carcinoma in situ. Clin Obstet Gynecol 1994;37:988-92.
136. Winchester D, Osteen R, Menck H. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996;68:1838-43.
137. Visser T, Haan M, Keidan R, et al. T1a and T1b breast cancer: a twelve-year experience. Am Surg 1997;63:621-6.
138. Sariego J, Zrada S, Byrd M, Matsumoto T. Breast cancer in young patients. Am J Surg 1995;170:243-5.
139. Sung J, Blumenthal D, Coates R, Williams J, Alema-Mensal E, Liff J. Effect of a cancer screening intervention conducted by lay health workers among inner-city women. Am J Prev Med 1997;13:51-7.
140. Parker S, Davis K, Wingo P, Ries L, Heath C Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin 1998;48:31-48.
141. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 1997;277:997-1003.
142. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
143. Shattuck-Eidens D, Oliphant A, McClure M, et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA 1997;278:1242-50.
144. Chen I. Who should be tested? Hippocrates 1997;11:50-60.
145. Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2. N Engl J Med 1997;336:1465-71.
146. Nemoto T, Vana J, Bedwani R, Baker H, McGregor F, Murphy G. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
147. O'Hea B, Hill A, El-Shirbiny A, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
148. Guiliano A, Dale P, Turner R, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
149. Veronesi U, Luini A, Mariani L, et al. Effect of menstrual phase on surgical treatment of breast cancer. Lancet 1994;343:1545-7.
150. Hudis C, Norton L. Adjuvant drug therapy for operable breast cancer. Semin Oncol 1996;23:475-93.
151. Starreveld A. A surgical subculture: the use of mastectomy to treat breast cancer. Can Med Assoc J 1997;156:43-5.
152. Nixon A, Troyan S, Harris J. Options in the local management of invasive breast cancer. Semin Oncol 1996;23:453-63.
153. Voogd A, Nab H, Crommelin M, van der Heijden L, Kluck H, Coeburgh J. Comparison of breast-conserving therapy with mastectomy for treatment of early breast cancer in community hospitals. Eur J Surg Oncol 1996;22:13-6.
154. Zissiadis Y, Langlands AO, Barraclough B, Boyages J. Breast conservation: long-term results form Westmead Hospital. Aust N Z J Surg 1997;67:313-9.
155. Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 1996;74:2024-31.
156. Blum J, Jones S, Fay J, Senzer N, Mennel R. Guidelines for systemic therapy of early stage breast cancer. Breast Cancer Res Treat 1997;43:259-76.
157. Hall PD, Lesher BA, Hall RK. Adjuvant therapy of nodenegative breast cancer. Ann Pharmacother 1995;29:289-98.
158. Chemotherapy benefits nearly all early breast cancer patients. J Natl Cancer Inst 1997;89:838-9.
159. Berkowitz L, Love N. Adjuvant systemic therapy for breast cancer. Postgrad Med 1995;98:85-94.
160. Buchholz TA, Austin-Seymour MM, Moe RE, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Rad One Biol Phys 1993;26:23-35.
161. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356-61.
162. Powles T. Efficacy of tamoxifen as treatment of breast cancer. Semin Oncol 1997;24Suppl 1:S1-S54.
163. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, and immune therapy: 133 Randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1-15.
164. Forbes JF. The control of breast cancer: the role of tamoxifen. Semin Oncol 1997;24Suppl:S1-S19.
165. Moore M, Kinne D. Tamoxifen therapy-long-term results and complications. Adv Surg 1996;29:263-9.
166. Bachmann G. Nonhormonal alternatives for the management of early menopause in younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:161-5.
167. Scott-Conner C, Schorr S. The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg 1995;170:401-5.
168. Marchant D. Breast cancer in pregnancy. Clin Obstet Gynecol 1994;37:993-7.
169. Isaacs J. Cancer of the breast in pregnancy. Surg Clin North Am 1995;75:47-51.
170. Dow K, Harris J, Coy C. Pregnancy after breast-conserving surgery and radiation therapy for breast cancer. J Natl Cancer Inst Monogr 1994;16:131-7.
171. Tralins A. Lactation after conservative breast surgery combined with radiation therapy. Am J Clin Oncol 1995;18:40-3.
172. Ranieri E, Virno F, D'Andrea MR, Carico E, D'Alessio A, Bergomi S, Vecchione A. The role of cytology in differentiation of breast lesions. Anticancer Res 1995;15:607-11.
173. King E, Goodson W. Discharges and secretions of the nipple. In Bland K, Copeland E, editors. The breast: comprehensive management of benign and malignant disease. Philadelphia: W.B. Saunders, 1991.
174. Petrakis N. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev 1993;15:188-95.
175. King E, Chew K, Petrakis N. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 1983;71:1115-21.
176. Wrensch M, Petrakis N, King E, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-41.
177. Carty NJ, Mudan SS, Ravichandran D, Royle GT, Taylor I. Prospective study of outcome in women presenting with nipple discharge. Ann R Coll Surg Engl 1994;76:387-9.
178. Isaacs J. Other nipple discharge. Clin Obstet Gynecol 1994;37:898-902.
179. Papanicolaou G, Holmquist D, Batter G, Faulk E. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other disease of the breast. Cancer 1958;11:377-409.